Literature DB >> 6165731

Serum ratio of triiodothyronine to thyroxine, and thyroxine-binding globulin and calcitonin concentrations in Graves' disease and destruction-induced thyrotoxicosis.

N Amino, Y Yabu, T Miki, S Morimoto, Y Kumahara, H Mori, Y Iwatani, K Nishi, K Nakatani, K Miyai.   

Abstract

The serum ratios of T3 to T4, and T4-binding globulin (TBG) and calcitonin concentrations were studied in cases of thyrotoxic Graves' disease and destruction-induced thyrotoxicosis. In 272 patients with Graves' disease, 209 of 240 (87%) untreated patients without complications had high T3 to T4 ratios (nanograms per micrograms) of more than 20. Six of 32 (19%) patients with Graves' disease who had complications (15 with pregnancy, 14 with increased TBG, and 3 with conditions associated with a low T3 syndrome) had high T3 to T4 ratios. Eleven of 74 (15%) patients with destruction-induced thyrotoxicosis (24 with subacute thyroiditis, 39 with postpartum transient thyrotoxicosis, and 11 with spontaneous transient thyrotoxicosis) had high T3 to T4 ratios. Patients who had serum T4 levels of more than 30 micrograms/dl and/or T3 levels of more than 800 ng/dl had Graves' disease. There was no significant correlation between the T3 to T4 ratio and activities of thyroid-stimulating immunoglobulins in thyrotoxic patients with Graves' disease who had no complications. The average serum levels of TBG in destruction-induced thyrotoxicosis and thyrotoxic Graves' disease were 20.7 +/- 4.3 micrograms/ml (mean +/- SD; n = 22), and 19.9 +/- 4.0 (n = 41), respectively, which were significantly lower than that in healthy subjects (22.7 +/- 4.4 micrograms/ml; n = 165), but there was no difference between the values in the two groups of thyrotoxicosis patients. The average serum level of calcitonin in destruction-induced thyrotoxicosis patients was 96.7 +/- 66.7 pg/ml (n = 21), which was significantly (P less than 0.05) higher than the values in patients with thyrotoxic Graves' disease (62.0 +/- 44.7 pg/ml; n = 26) and in healthy subjects (63.9 +/- 31.2 pg/ml; n = 29), but the difference in values in the two groups of thyrotoxicosis was not clinically useful because of considerable overlap of individual values. The T3 to T4 ratio is a simple and helpful index for the differentiation of the two types of thyrotoxicosis. A T3 to T4 ratio less than 20 in thyrotoxic patients before therapy is a laboratory signal of destruction-induced thyrotoxicosis or Graves' disease with complications, but final differentiation should be confirmed by measuring radioactive iodine uptake.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165731     DOI: 10.1210/jcem-53-1-113

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  23 in total

1.  Thyroid ultrasonography related to clinical and laboratory findings in patients with silent thyroiditis.

Authors:  M Miyakawa; T Tsushima; N Onoda; M Etoh; O Isozaki; M Arai; K Shizume; H Demura
Journal:  J Endocrinol Invest       Date:  1992-04       Impact factor: 4.256

2.  Thirty-five cases of transient hyperthyroidism.

Authors:  J K McConnon
Journal:  Can Med Assoc J       Date:  1984-05-01       Impact factor: 8.262

3.  Thyrotoxic Graves' disease with normal thyroidal technetium-99m pertechnetate uptake.

Authors:  K Ikekubo; M Hino; H Ito; T Koh; T Ishihara; H Kurahachi; K Kasagi; A Hidaka; T Mori
Journal:  Ann Nucl Med       Date:  1990-07       Impact factor: 2.668

Review 4.  Eponym : de Quervain thyroiditis.

Authors:  Pontipa Engkakul; Pat Mahachoklertwattana; Preamrudee Poomthavorn
Journal:  Eur J Pediatr       Date:  2010-10-01       Impact factor: 3.183

5.  Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.

Authors:  Danae A Delivanis; Michael P Gustafson; Svetlana Bornschlegl; Michele M Merten; Lisa Kottschade; Sarah Withers; Allan B Dietz; Mabel Ryder
Journal:  J Clin Endocrinol Metab       Date:  2017-08-01       Impact factor: 5.958

6.  Transient thyrotoxicosis in a patient with a functioning nodule; a possible occurrence of silent thyroiditis.

Authors:  K Kasagi; S Matsumoto; R Takeuchi; T Misaki; J Konishi
Journal:  Ann Nucl Med       Date:  1992-05       Impact factor: 2.668

7.  Hunger-satiety signals in patients with Graves' thyrotoxicosis before, during, and after long-term pharmacological treatment.

Authors:  Sven Röjdmark; Jan Calissendorff; Olle Danielsson; Kerstin Brismar
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

8.  Thyroid hormone metabolism in thyroid disease as reflected by the ratio of serum triiodothyronine to thyroxine.

Authors:  E M Erfurth; P Hedner
Journal:  J Endocrinol Invest       Date:  1986-10       Impact factor: 4.256

Review 9.  Thyroid ultrasonography.

Authors:  Yasuhiro Ito; Nobuyuki Amino; Akira Miyauchi
Journal:  World J Surg       Date:  2010-06       Impact factor: 3.352

10.  Increased serum interleukin-6 concentration in patients with subacute thyroiditis: relationship with concomitant changes in serum T4-binding globulin concentration.

Authors:  L Bartalena; S Brogioni; L Grasso; E Martino
Journal:  J Endocrinol Invest       Date:  1993-03       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.